Search

Author/Creator Levitan, Bennett

1. Improved Benefit Risk Profile of Rivaroxaban in a Subpopulation of the MAGELLAN Study. (19th November 2019)

Authors:
Spyropoulos, Alex C.; Lipardi, Concetta; Xu, Jianfeng; Lu, Wentao; Suh, Eunyoung; Yuan, Zhong; Levitan, Bennett; Sugarmann, Chiara; De Sanctis, Yoriko; Spiro, Theodore E.; Barnathan, Elliot S.; Raskob, Gary E.
Journal:
Clinical and applied thrombosis/hemostasis
Issue:
Volume 25(2019)
Page Start:
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

2. Cost comparison of continued anticoagulation with rivaroxaban versus placebo based on the 1-year EINSTEIN-Extension trial efficacy and safety results. (3rd June 2018)

Authors:
Wells, Philip S.; Lensing, Anthonie W. A.; Haskell, Lloyd; Levitan, Bennett; Laliberté, François; Durkin, Michael; Ashton, Veronica; Xiao, Yongling; Crivera, Concetta; Lejeune, Dominique; Schein, Jeff; Lefebvre, Patrick
Journal:
Journal of medical economics
Issue:
Volume 21:Number 6(2018)
Page Start:
587
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

6. Benefits and risks of extended treatment of venous thromboembolism with rivaroxaban or with aspirin. Issue 168 (August 2018)

Authors:
Prandoni, Paolo; Lensing, Anthonie W.A.; Prins, Martin H.; Gebel, Martin; Pap, Akos F.; Homering, Martin; Bauersachs, Rupert; Beyer-Westendorf, Jan; Bounameaux, Henri; Cohen, Alexander T.; Davidson, Bruce L.; van Bellen, Bonno; Verhamme, Peter; Wells, Philip S.; Yuan, Zhong; Levitan, Bennett; Wei...
Journal:
Thrombosis research
Issue:
Issue 168(2018)
Page Start:
121
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

9. Assessing the Financial Value of Patient Engagement: A Quantitative Approach from CTTI's Patient Groups and Clinical Trials Project. (March 2018)

Authors:
Levitan, Bennett; Getz, Kenneth; Eisenstein, Eric L.; Goldberg, Michelle; Harker, Matthew; Hesterlee, Sharon; Patrick-Lake, Bray; Roberts, Jamie N.; DiMasi, Joseph
Journal:
Therapeutic innovation & regulatory science
Issue:
Volume 52:Number 2(2018:Mar.)
Page Start:
220
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

10. Patient Engagement at a Tipping Point—The Need for Cultural Change Across Patient, Sponsor, and Regulator Stakeholders: Insights From the DIA Conference, "Patient Engagement in Benefit Risk Assessment Throughout the Life Cycle of Medical Products". (September 2016)

Authors:
Smith, Meredith Y.; Hammad, Tarek A.; Metcalf, Marilyn; Levitan, Bennett; Noel, Rebecca; Wolka, Anne M.; Michaels, Debra L.; Johnson, F. Reed
Journal:
Therapeutic innovation & regulatory science
Issue:
Volume 50:Number 5(2016:Sep.)
Page Start:
546
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗